Physician profile
David Bowers
NPI 1457391997
$917.88
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $38.36 · 2021: $82.66 · 2023: $348 · 2024: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $166.34 | 2023-2024 | Sprint Pns System |
| Vertos Medical, INC. | $117.42 | 2023-2024 | Mild Device Kit |
| Djo, LLC | $78.87 | 2023-2024 | Cmf, Chattanooga |
| Painteq LLC | $70.84 | 2024 | Painteq |
| Pacira Therapeutics, INC. | $62.78 | 2019 | |
| Nevro Corp. | $62.50 | 2023 | Senza |
| Redhill Biopharma INC. | $60.20 | 2021 | |
| Pfizer INC. | $51.89 | 2019-2020 | |
| Radius Health, INC. | $46.24 | 2019 | |
| Abbott Laboratories | $44.08 | 2019 | |
| Abbvie INC. | $41.52 | 2023 | Botox |
| Assertio Therapeutics, INC. | $39.36 | 2019-2020 | |
| Bioventus LLC | $29.56 | 2019 | |
| Nalu Medical, INC. | $23.82 | 2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $22.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.